← Back to Search

Home Alone Program for Cognitive Impairment

N/A
Recruiting
Led By Joseph Gaugler, PhD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Demonstrates capacity to consent
Lives alone in a non-residential setting
Must not have
Are not English speaking
Have not remained on a stable psychotropic medications dosage, such as antidepressants, anxiolytics, or anti-psychotics, for the prior three months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up phase ii at 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to evaluate a program to help older adults with cognitive impairment who live alone to stay safe and engaged. Participants will complete 3 surveys, 7 weekly meetings with a coach, and a final interview.

Who is the study for?
This trial is for U.S. residents aged 55 or older who live alone, can consent to participate, and have cognitive impairment (CI). They must either have a provider's diagnosis of CI, score between 13-18 on the T-MoCA test, or feel they have memory issues. Excluded are those in assisted living, non-English speakers, participants in similar services, those unwilling or unable to engage actively in the intervention, and individuals with untreated mental health conditions.
What is being tested?
The 'Home Alone' program is being tested over two phases: Phase I involves a three-month commitment with weekly meetings and surveys; Phase II extends this to six months. The program aims to help cognitively impaired adults who live alone remain active and safe at home by providing coaching sessions.
What are the potential side effects?
Since 'Home Alone' is not a medication but an engagement and safety program for people with cognitive impairments living alone, it does not have side effects like drugs do. However, participation requires time commitment for meetings and surveys.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I understand and can agree to medical procedures.
Select...
I live by myself in a home or apartment.
Select...
I am 55 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak English.
Select...
I have changed my mental health medication dosage in the last 3 months.
Select...
My mental health condition is new or getting worse, and I am not currently receiving treatment for it.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~phase ii at 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and phase ii at 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of Intervention
Feasibility of Intervention
Intervention Appropriateness
+1 more
Secondary study objectives
Activity/Engagement
Behavioral Activation Scale
Cognition
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Home Alone InterventionExperimental Treatment1 Intervention
Home Alone is a semi-structured intervention, tailored to address the individual needs and concerns of the older adult. The participant will engage in about seven psychoeducational coaching sessions, each lasting approximately one hour. The intervention has two key foci: 1. increasing or maintaining home safety and comfort 2. increasing scheduled social engagements and activities. Sessions are also designed to identify formal and informal services and supports to improve to increase assistance and ability to live independently for as long as safely possible. The sessions take place either in-person or remotely (via secure video conferencing or telephone). Ad hoc/ongoing sessions may be provided as needed.

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,439 Previous Clinical Trials
1,621,893 Total Patients Enrolled
Joseph Gaugler, PhDPrincipal InvestigatorUniversity of Minnesota
1 Previous Clinical Trials
208 Total Patients Enrolled

Media Library

Home Alone Clinical Trial Eligibility Overview. Trial Name: NCT05746390 — N/A
Cognitive Impairment Research Study Groups: Home Alone Intervention
Cognitive Impairment Clinical Trial 2023: Home Alone Highlights & Side Effects. Trial Name: NCT05746390 — N/A
Home Alone 2023 Treatment Timeline for Medical Study. Trial Name: NCT05746390 — N/A
~3 spots leftby Feb 2025